Bank of New York Mellon Corp - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2018$18,829,000
+17.5%
968,076
+0.6%
0.01%
+25.0%
Q4 2017$16,027,000
-14.7%
962,695
+4.0%
0.00%
-20.0%
Q3 2017$18,788,000
+20.1%
925,503
-4.8%
0.01%
+25.0%
Q2 2017$15,646,000
+32.7%
971,823
+4.2%
0.00%
+33.3%
Q1 2017$11,794,000
+1.5%
932,320
+6.3%
0.00%0.0%
Q4 2016$11,617,000
-45.6%
876,764
-2.7%
0.00%
-50.0%
Q3 2016$21,366,000
-9.9%
901,521
+9.6%
0.01%
-14.3%
Q2 2016$23,714,000
-11.7%
822,854
-1.9%
0.01%
-12.5%
Q1 2016$26,863,000
-22.5%
838,938
+3.5%
0.01%
-20.0%
Q4 2015$34,665,000
+20.6%
810,694
-0.7%
0.01%
+11.1%
Q3 2015$28,755,000
-7.6%
816,673
+20.5%
0.01%0.0%
Q2 2015$31,113,000
-3.0%
677,549
-1.0%
0.01%
+12.5%
Q1 2015$32,063,000
+48.8%
684,082
+0.6%
0.01%
+33.3%
Q4 2014$21,547,000
+35.5%
680,111
+1.4%
0.01%
+50.0%
Q3 2014$15,907,000
-65.1%
670,820
-55.8%
0.00%
-33.3%
Q2 2014$45,566,000
+133.7%
1,519,362
+105.9%
0.01%
+20.0%
Q1 2014$19,494,000
+14.7%
737,884
+9.1%
0.01%0.0%
Q4 2013$16,998,000
-36.5%
676,082
-48.3%
0.01%
+25.0%
Q3 2013$26,750,000
+87.1%
1,306,790
+82.3%
0.00%
-20.0%
Q2 2013$14,295,000716,9020.01%
Other shareholders
IMPAX LABORATORIES INC shareholders Q4 2013
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 423,161$13,406,0007.47%
Aravt Global 2,300,000$72,864,0005.43%
Slate Path Capital LP 2,330,000$73,814,0005.16%
Orbimed Advisors 6,678,000$211,559,0002.02%
Iguana Healthcare Management, LLC 100,000$3,168,0001.53%
Iguana Healthcare Management, LLC 100,000$3,168,0001.53%
Penn Capital Management Company, LLC 709,045$22,463,0000.94%
HUSSMAN STRATEGIC ADVISORS, INC. 250,000$7,920,0000.79%
NEW AMSTERDAM PARTNERS LLC/NY 276,169$8,749,0000.76%
Matarin Capital Management, LLC 52,932$1,676,886,0000.74%
View complete list of IMPAX LABORATORIES INC shareholders